Advanced INCUBEยฎ 501 and 701 materials apply metalโorganic framework science to skin regeneration
H2MEDI integrates MOF-based actives to introduce a dual-action system for inflammation control and post-procedure recovery
[๋น์๋ํฌ์คํธ ๊น์ ๊ธฐ์] A technology recognized in the 2025 Nobel Prize in Chemistry is gaining new momentum in the field of skin regeneration. The prize was awarded to Professors Susumu Kitagawa, Richard Robson, and Omar M. Yaghi for their pioneering development of metalโorganic frameworks (MOFs), a class of porous crystalline materials often described as โmolecular spongesโ for their ability to precisely bind metal ions and organic molecules at the atomic level.
MOFs are now applied across a range of industries, from carbon-capture and air purification to water harvesting and targeted drug delivery. UC Berkeley Professor Omar M. Yaghi, one of the award recipients, advanced the field by stabilizing MOF structures and enabling highly selective adsorption and controlled release of specific molecules โ a breakthrough that has strengthened the materialโs potential in the pharmaceutical and biotechnology sectors.
MOF-Based Dual Regeneration System: INCUBEยฎ 501 and 701
Following the Nobel announcement, the dermatology platform LHALA Doctor has attracted attention for integrating MOF-based materials into its skin-recovery technology. The system incorporates INCUBEยฎ 501 and INCUBEยฎ 701, two proprietary actives developed by LabIncube Co., a subsidiary of Sookmyung Womenโs University Technology Holdings.
INCUBEยฎ 501 uses highly precise MOF particles smaller than 10 ฮผm to selectively adsorb inflammatory mediators such as cytokines, reactive oxygen species (ROS), and nitric oxide (NO). The material functions not only as a delivery system but also as an active agent that removes pro-inflammatory substances while promoting tissue repair, aiming to reduce post-procedure hypersensitivity and hyperpigmentation.
INCUBEยฎ 701 consists of uniformly spherical PLLA (poly-L-lactic acid) particles measuring 30โ80 ฮผm, designed to stimulate collagen production and support skin-structure rebuilding. Together, the two materials form a dual-action regeneration mechanism that clears inflammation triggers while boosting the skinโs natural recovery processes.
LHALA Doctor Positions Itself as โTherapeutic Peelingโ
Positioned as a next-generation regenerative peeling platform, LHALA Doctor applies a clinical concept described as โPeel(-) and Fill(+).โ The formulation combines INCUBEยฎ 501 and 701 with additional functional ingredients such as a quantum-dot complex for light-based synergy, calcium oxide for epidermal-barrier reinforcement, and a blend of LHA, H2solโข, and lipids for controlled exfoliation and pigmentation improvement.
The company behind LHALA Doctor, H2MEDI, states that the platform is intended to redefine conventional peeling by focusing on recovery, repair, and post-procedure stability โ areas where demand continues to rise in the medical aesthetics industr
MOF Technology Extends Beyond Chemistry
The incorporation of INCUBEยฎ 501 and 701 into dermatological applications marks one of the clearest demonstrations to date that MOF materials can transition from environmental and chemical engineering into skin-regeneration science.
LabIncube, which developed the INCUBEยฎ series based on MOF materials associated with this yearโs Nobel Prize, reports growing global interest in MOF-based dermatology solutions due to their high molecular precision and potential for targeted therapeutic action.
As the medical aesthetics field increasingly adopts advanced material science, LHALA Doctor is emerging as an early example of how Nobel Prizeโrecognized technologies can translate into practical innovations aimed at clinical efficacy and patient safety.ย
Advanced INCUBEยฎ 501 and 701 materials apply metalโorganic framework science to skin regeneration
H2MEDI integrates MOF-based actives to introduce a dual-action system for inflammation control and post-procedure recovery
[๋น์๋ํฌ์คํธ ๊น์ ๊ธฐ์] A technology recognized in the 2025 Nobel Prize in Chemistry is gaining new momentum in the field of skin regeneration. The prize was awarded to Professors Susumu Kitagawa, Richard Robson, and Omar M. Yaghi for their pioneering development of metalโorganic frameworks (MOFs), a class of porous crystalline materials often described as โmolecular spongesโ for their ability to precisely bind metal ions and organic molecules at the atomic level.
MOFs are now applied across a range of industries, from carbon-capture and air purification to water harvesting and targeted drug delivery. UC Berkeley Professor Omar M. Yaghi, one of the award recipients, advanced the field by stabilizing MOF structures and enabling highly selective adsorption and controlled release of specific molecules โ a breakthrough that has strengthened the materialโs potential in the pharmaceutical and biotechnology sectors.
MOF-Based Dual Regeneration System: INCUBEยฎ 501 and 701
Following the Nobel announcement, the dermatology platform LHALA Doctor has attracted attention for integrating MOF-based materials into its skin-recovery technology. The system incorporates INCUBEยฎ 501 and INCUBEยฎ 701, two proprietary actives developed by LabIncube Co., a subsidiary of Sookmyung Womenโs University Technology Holdings.
INCUBEยฎ 501 uses highly precise MOF particles smaller than 10 ฮผm to selectively adsorb inflammatory mediators such as cytokines, reactive oxygen species (ROS), and nitric oxide (NO). The material functions not only as a delivery system but also as an active agent that removes pro-inflammatory substances while promoting tissue repair, aiming to reduce post-procedure hypersensitivity and hyperpigmentation.
INCUBEยฎ 701 consists of uniformly spherical PLLA (poly-L-lactic acid) particles measuring 30โ80 ฮผm, designed to stimulate collagen production and support skin-structure rebuilding. Together, the two materials form a dual-action regeneration mechanism that clears inflammation triggers while boosting the skinโs natural recovery processes.
LHALA Doctor Positions Itself as โTherapeutic Peelingโ
Positioned as a next-generation regenerative peeling platform, LHALA Doctor applies a clinical concept described as โPeel(-) and Fill(+).โ The formulation combines INCUBEยฎ 501 and 701 with additional functional ingredients such as a quantum-dot complex for light-based synergy, calcium oxide for epidermal-barrier reinforcement, and a blend of LHA, H2solโข, and lipids for controlled exfoliation and pigmentation improvement.
The company behind LHALA Doctor, H2MEDI, states that the platform is intended to redefine conventional peeling by focusing on recovery, repair, and post-procedure stability โ areas where demand continues to rise in the medical aesthetics industr
MOF Technology Extends Beyond Chemistry
The incorporation of INCUBEยฎ 501 and 701 into dermatological applications marks one of the clearest demonstrations to date that MOF materials can transition from environmental and chemical engineering into skin-regeneration science.
LabIncube, which developed the INCUBEยฎ series based on MOF materials associated with this yearโs Nobel Prize, reports growing global interest in MOF-based dermatology solutions due to their high molecular precision and potential for targeted therapeutic action.
As the medical aesthetics field increasingly adopts advanced material science, LHALA Doctor is emerging as an early example of how Nobel Prizeโrecognized technologies can translate into practical innovations aimed at clinical efficacy and patient safety.ย